Almirall stock edges lower as investors weigh H1 2026
Published on 09/10/2026 at 16:54 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Almirall stock (ES0157097017) closed at EUR 78.20 on September 9, 2026, down 2.25 percent on 45,743 shares traded. The move left the Barcelona-based drugmaker inside its 2026 trading range, with the latest session still reflecting the half-year report as the main reference point.
Half-year figures still matter
According to ad hoc news, Almirall's latest half-year figures for H1 2026 remain the key operating anchor for the stock on September 10, 2026. The same report says management kept full-year 2026 guidance in place while still pointing to continued growth in dermatology, especially in Europe.
That matters because the market is now comparing the EUR 78.20 share price with a consensus target of EUR 102.94. The gap is 31.7 percent, and that is before any fresh earnings update.
Consensus and valuation
According to MarketScreener, 8 analysts cover Almirall and the average price target stands at EUR 102.94, with the latest close at EUR 80.00 in the same data set. MarketScreener also shows a year-to-date gain of 4.14 percent and a 52-week range of EUR 64.00 to EUR 105.20.
For investors, the combination of a EUR 78.20 close, a EUR 102.94 average target and a year-to-date move of 4.14 percent keeps valuation central. The stock is not priced for a rerating without either stronger execution or a clearer growth step in the next update.
Price stays in range
Almirall stock ended the session at EUR 78.20 on September 9, 2026, with the 2026 range on MarketScreener spanning EUR 64.00 to EUR 105.20. Turnover of 45,743 shares suggests a relatively measured session rather than a decisive break.
Almirall at a glance
- Company: Almirall, S.A.
- ISIN: ES0157097017
- Ticker: ALM
- Trading venue: BME
- Price (as of September 9, 2026): EUR 78.20
- Market capitalization: EUR 1.4 billion (as of September 9, 2026)
- Sector / Industry: Pharmaceuticals
- Index membership: not stated in the available market data
